Literature DB >> 16312196

Cemento-osseous dysplasia in Jamaica: review of six cases.

C Ogunsalu1, D Miles.   

Abstract

Six cases of cemento-osseous dysplasia (COD) of the jaw bone in Jamaicans are reviewed. Five were documented over a 15-year period (1980-1995). These include a case of florid cemento-osseous dysplasia (previously called gigantiform cementoma). Three of the initial cases were histologically diagnosed as gigantiform cementoma. There was no indication in the patient's case file whether these were familial or non-familial. The other two cases were diagnosed histologically as periapical cemento-osseous dysplasia and cementoblastoma respectively. Based on the current understanding of the nature of florid-cemento-osseous dysplasia (FLCOD), a new case was diagnosed as such solely on radiological findings. This single case of FLCOD is reported and discussed against the background of other cemento-osseous lesions. Special emphasis is placed on the radiology of COD in this paper. The confirmative role of radiology without the need for histophathology and treatment for asymptomatic FLCOD is emphasized.

Entities:  

Mesh:

Year:  2005        PMID: 16312196     DOI: 10.1590/s0043-31442005000400012

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  3 in total

Review 1.  Florid cemento-osseous dysplasia: review of an uncommon fibro-osseous lesion of the jaw with important clinical implications.

Authors:  Sarah Fenerty; Wei Shaw; Rahul Verma; Ali B Syed; Riya Kuklani; Jie Yang; Sayed Ali
Journal:  Skeletal Radiol       Date:  2017-02-13       Impact factor: 2.199

2.  Gigantiform cementoma in a child.

Authors:  C E E Noffke; S P Ngwenya; N Nzima; E J Raubenheimer; N B Rakgwale
Journal:  Dentomaxillofac Radiol       Date:  2012-03       Impact factor: 2.419

3.  A retrospective clinico-pathologic analysis of cemento-osseous dysplasia in a South African patient population.

Authors:  Mouna M Benaessa; Farzana Mahomed; Sizakele P Ngwenya
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.